SEC Form 4 · accession 0001062822-26-000102
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Debbane
Director
Period of report
Jun 3, 2026
Accepted (ET)
Jun 4, 2026 · 4:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 3, 2026 | M | 89,312 | $0.00 | A | 1,995,498 | D | |
| Common Stock | holding | — | — | — | 1,538,462 | I | By Avicenna Life Sci Master Fund LP and related parties | |
| Common Stock | holding | — | — | — | 7,362,368 | I | By Invus Public Equities, L.P. and related parties | |
| Common Stock | holding | — | — | — | 5,451,204 | I | By Invus US Partners, LLC and related parties | |
| Common Stock | holding | — | — | — | 35,402,689 | I | By Invus, L.P. and related parties |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Jun 3, 2026 | M | 89,312 | D | — | — | Common Stock | 89,312 | 0 | D |
Explanation of responses
- F1Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock.